Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
Related Questions
How do you approach selecting optimal muscle biopsy site when evaluating a patient for suspected inflammatory myopathy?
What do you consider when there is incidentally found patchy peripheral nerve enlargement on imaging with otherwise unremarkable clinical and electrophysiological findings?
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
When would you consider testing for LGI1 antibodies in patients with unexplained neuropathic pain?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
How do you manage anxiety for patients who are experiencing a myasthenic crisis?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
How do you decide when to add steroid-sparing immunotherapy for myasthenia gravis after starting prednisone and Mestinon?
How do you adjust chronic outpatient steroid therapy when myasthenia gravis patients are admitted for crisis?
